Precision Cancer Medicine Registration Study of Omics Data from Genomic Information Analysis Leading to New Effective Therapy
Not Applicable
Recruiting
- Conditions
- a) any cancer that becomes refractory/intolerant to standard therapy b) cancer of unknown primary c) rare malignancy
- Registration Number
- JPRN-UMIN000028439
- Lead Sponsor
- Tokyo Medical and Dental University Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
- those who cannot consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The following items will be recorded in the registry. a. Demographic (age, sex, co-morbidities, family history, social history) b. Diagnosis (tumor type, histology, primary site, metastatic site, stage) c. Treatment (modality, regimen, response, duration of response, adverse event, QOL) d. Genomic alteration (method, QC, gene name, alteration type, details of alteration etc.) e. Outcome (overall survival, disease-free survival, progression-free survival, relapse-free survival etc.)
- Secondary Outcome Measures
Name Time Method